Katrien O. François

Author

Katrien O. François

Rega Institute for Medical Research

Also Known As

K. François, K. O. François, Katrien François, Katrien O. François, Katrien O. François, Katrien Omer François

Publications

466

Citations

H-Index

Concepts

All Affiliations

Rega Institute for Medical Research KU Leuven

About

Katrien O. François is an author at Rega Institute for Medical Research specializing in hiv, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	120
2	Natural Sciences	4	4	130
3	Biochemistry	4	4	130
4	Biomolecular Engineering	2	2	57
5	Chemical Biology	1	1	11

Katrien O. François

Publications

359

Citations

H-Index

Page 1

	Year	Citations
Multi-centre evaluation of a comprehensive preimplantation genetic test through haplotyping-by-sequencing Heleen Masset, Masoud Zamani Esteki, Eftychia Dimitriadou, Human Reproduction	2019	64
Actinohivin, a Broadly Neutralizing Prokaryotic Lectin, Inhibits HIV-1 Infection by Specifically Targeting High-Mannose-Type Glycans on the gp120 Envelope Bart Hoorelbeke, Dana Huskens, Geoffrey Férir, Antimicrobial Agents and Chemotherapy	2010	56
Pradimicin S, a Highly Soluble Nonpeptidic Small-Size Carbohydrate-Binding Antibiotic, Is an Anti-HIV Drug Lead for both Microbicidal and Systemic Use Jan Balzarini, Katrien O. François, Kristel Van Laethem, Antimicrobial Agents and Chemotherapy ImmunologyAntimicrobial ChemotherapyAntiviral DrugDrug ResistanceMedicinal Chemistry	2010	46
Thioredoxin-1 and protein disulfide isomerase catalyze the reduction of similar disulfides in HIV gp120 Kathrin Reiser, Katrien O. François, Dominique Schols, The International Journal of Biochemistry & Cell Biology Similar DisulfidesBiochemistryNatural SciencesHuman RetrovirusMolecular Biology	2012	41
Deletion of the Highly Conserved N-Glycan at Asn260 of HIV-1 gp120 Affects Folding and Lysosomal Degradation of gp120, and Results in Loss of Viral Infectivity Leen Mathys, Katrien O. François, Matthias Quandte, PLoS ONE	2014	32
The Highly Conserved Glycan at Asparagine 260 of HIV-1 gp120 Is Indispensable for Viral Entry Katrien O. François, Jan Balzarini Journal of Biological Chemistry	2011	32
Glycan deletions in the HIV-1 gp120 V1/V2 domain compromise viral infectivity, sensitize the mutant virus strains to carbohydrate-binding agents and represent a specific target for therapeutic intervention Katrien O. François, Kris Covens, Kristel Van Laethem, Virology GlycoproteomicsGlycosylationBiochemistryNatural SciencesMutant Virus Strains	2008	32
Feglymycin, a unique natural bacterial antibiotic peptide, inhibits HIV entry by targeting the viral envelope protein gp120 Geoffrey Férir, Anne Hänchen, Katrien O. François, Virology Hiv EntryHuman RetrovirusImmunologyAntiviral Drug DevelopmentAntiviral Response	2012	21
Simian Immunodeficiency Virus Is Susceptible to Inhibition by Carbohydrate-Binding Agents in a Manner Similar to That of HIV: Implications for Further Preclinical Drug Development Katrien O. François, Dominique Schols, Jan Balzarini Molecular Pharmacology	2008	14
The Phthalocyanine Prototype Derivative Alcian Blue Is the First Synthetic Agent with Selective Anti-Human Immunodeficiency Virus Activity Due to Its gp120 Glycan-Binding Potential Katrien O. François, Christophe Pannecouque, Virginia Lozano, Antimicrobial Agents and Chemotherapy Alcian BlueBioorganic ChemistryGlycobiologyImmunologyMolecular Biology	2009	11

Page 1